(Q35957526)

11 August 2017

Feeling energetic? New strategies to prevent metabolic reprogramming in melanoma (English)

1 reference

11 August 2017

2

Keith T Flaherty

1 reference

11 August 2017

3

Keiran S M Smalley

1 reference

11 August 2017

1

Daniel Verduzco

1 reference

11 August 2017

23 May 2015

1 reference

11 August 2017

Experimental Dermatology

1 reference

11 August 2017

24

1 reference

11 August 2017

9

1 reference

11 August 2017

657-658

1 reference

Improved overall survival in melanoma with combined dabrafenib and trametinib

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537671

Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma.

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FEXD.12763

21 January 2018

Identifiers

DOI

10.1111/EXD.12763

1 reference

11 August 2017

1 reference

PMC publication ID

4537671

11 August 2017

PubMed publication ID

26010519

1 reference

PMC publication ID

4537671